DekaBank Deutsche Girozentrale’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-6,900
| Closed | -$379K | – | 1496 |
|
|
2021
Q3 | $379K | Hold |
6,900
| – | – | ﹤0.01% | 1108 |
|
|
2021
Q2 | $288K | Hold |
6,900
| – | – | ﹤0.01% | 1154 |
|
|
2021
Q1 | $282K | Hold |
6,900
| – | – | ﹤0.01% | 1126 |
|
|
2020
Q4 | $319K | Hold |
6,900
| – | – | ﹤0.01% | 1111 |
|
|
2020
Q3 | $286K | Buy |
+6,900
| New | +$286K | ﹤0.01% | 1001 |
|
|
2019
Q4 | – | Sell |
-6,900
| Closed | -$389K | – | 1235 |
|
|
2019
Q3 | $389K | Sell |
6,900
-6,900
| -50% | -$389K | ﹤0.01% | 797 |
|
|
2019
Q2 | $759K | Buy |
13,800
+5,300
| +62% | +$292K | ﹤0.01% | 839 |
|
|
2019
Q1 | $581K | Buy |
8,500
+1,600
| +23% | +$109K | ﹤0.01% | 882 |
|
|
2018
Q4 | $268K | Sell |
6,900
-1,600
| -19% | -$62.1K | ﹤0.01% | 928 |
|
|
2018
Q3 | $581K | Sell |
8,500
-200
| -2% | -$13.7K | ﹤0.01% | 902 |
|
|
2018
Q2 | $661K | Hold |
8,700
| – | – | ﹤0.01% | 845 |
|
|
2018
Q1 | $454K | Sell |
8,700
-200
| -2% | -$10.4K | ﹤0.01% | 882 |
|
|
2017
Q4 | $496K | Hold |
8,900
| – | – | ﹤0.01% | 822 |
|
|
2017
Q3 | $496K | Hold |
8,900
| – | – | ﹤0.01% | 828 |
|
|
2017
Q2 | $702K | Hold |
8,900
| – | – | 0.01% | 769 |
|
|
2017
Q1 | $738K | Sell |
8,900
-750
| -8% | -$62.2K | 0.01% | 662 |
|
|
2016
Q4 | $756K | Buy |
9,650
+750
| +8% | +$58.8K | 0.01% | 590 |
|
|
2016
Q3 | $623K | Hold |
8,900
| – | – | 0.01% | 630 |
|
|
2016
Q2 | $346K | Sell |
8,900
-400
| -4% | -$15.6K | ﹤0.01% | 755 |
|
|
2016
Q1 | $363K | Buy |
+9,300
| New | +$363K | ﹤0.01% | 720 |
|